Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

123.54 -1.53 (-1.22%)
Official Closing Price Updated: 4:10 PM EDT, Jul 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Top dow jones movers in Friday's session ↗
Via Chartmill
News headline image
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With Padcev® (enfortumab vedotin-ejfv), as Treatment Before and After Surgery for Adults With Muscle-Invasive Bladder Cancer (MIBC)
From Merck & Co., Inc.
Via Business Wire
Exploring the top movers within the dow jones index during today's session. ↗
Via Chartmill
Exploring the top movers within the dow jones index during today's session. ↗
Via Chartmill
Stay informed with the top movers within the dow jones index on Wednesday. ↗
Via Chartmill
Exploring the top movers within the dow jones index during today's session. ↗
Via Chartmill
News headline image
3 Reasons to Buy Novo Nordisk Stock ↗
The stock is down, but it isn't out yet. 
Via The Motley Fool
News headline image
U.S. Healthcare Spending Just Hit $5.7 Trillion and Continues to Grow: 2 Stocks to Buy to Profit From the Trend ↗
Good medical care will always be in high demand, which makes some healthcare stocks strong long-term picks. 
Via The Motley Fool
What's going on in today's session: dow jones movers ↗
Via Chartmill
News headline image
The Dividend ETF Quietly Outperforming the S&P 500 ↗
This dividend ETF's focus beyond yield continues to pay off for investors. 
Via The Motley Fool
Topics ETFs Stocks
Which S&P500 stocks are showing activity after the closing bell on Monday? ↗
Via Chartmill
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
What's going on in today's session: dow jones movers ↗
Via Chartmill
Wall Street Got the Weak Jobs Report It Wanted. Chip Stocks Wrecked the Rally Anyway. ↗
Via Chartmill
News headline image
If You Put $10,000 in This Dividend ETF 15 Years Ago, Here's How Much You'd Have Today (Hint: It's a Lot) ↗
The Schwab U.S. Dividend Equity ETF is anything but boring. 
Via The Motley Fool
Topics ETFs Stocks
Which dow jones stocks are moving on Thursday? ↗
Via Chartmill
Which dow jones stocks are moving on Wednesday? ↗
Via Chartmill
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
News headline image
Merck to Hold Second-Quarter 2026 Sales and Earnings Conference Call Aug. 4
From Merck & Co., Inc.
Via Business Wire
News headline image
3 Magnificent Dividend ETFs That Could Supercharge Your Passive Income ↗
All three ETFs complement each other well in a portfolio. 
Via The Motley Fool
Topics ETFs Stocks
News headline image
Merck Announces New Agreement with ADAP Crisis Task Force to Improve Access and Care for People Living with HIV
From Merck & Co., Inc.
Via Business Wire
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
Stay informed with the top movers within the dow jones index on Thursday. ↗
Via Chartmill
What's going on in today's session: dow jones movers ↗
Via Chartmill
News headline image
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), each with Trodelvy® (sacituzumab govitecan-hziy) as First-Line Treatment of PD-L1+ (CPS ≥10) Advanced Triple-Negative Breast Cancer (TNBC)
From Merck & Co., Inc.
Via Business Wire
Wednesday's session: top gainers and losers in the dow jones index ↗
Via Chartmill
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
Via Investor Brand Network
The Quest to Repair What Multiple Sclerosis Takes Away
Via Investor Brand Network
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis
Via Investor Brand Network
BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Targets Next Generation of DNA Damage Response Cancer Therapies
Via Investor Brand Network
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.